“…In 417 individuals considered at risk for heart failure (e.g., history of hypertension, diabetes, obesity, or having received potential cardiotoxic chemotherapy) enrolled through local media advertising, the P-wave terminal force in lead V1 (PTFV1) ≤ −4,000 µV * ms showed a PPV of 67% and a sensitivity of 36% for LVDD (prevalence LVDD = 65%) (21). In another study with individuals undergoing echocardiography as part of routine cardiac care (20), the sensitivity, specificity, PPV, and NPV of a PTFV1 ≥0.04 mm * s were 27, 100, 100, and 38%, respectively, for a diagnosis of LVDD [present in 62 of 117 participants (53%)]. In 8 among the 117 participants (6.8%), the Morris index was present resulting in a sensitivity, specificity, and PPV and NPV for LVDD of 13, 100, 100, and 34%, respectively (20).…”